These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6769935)

  • 1. Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.
    Koulu M; Lammintausta R; Dahlström S
    J Clin Endocrinol Metab; 1980 Jul; 51(1):124-9. PubMed ID: 6769935
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men.
    Coiro V; Capretti L; Bianconi L; Castelli A; Cerri L; Roberti G; Marcato A; Volpi R; Chiodera P
    Horm Metab Res; 1991 Dec; 23(12):600-4. PubMed ID: 1663914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAergic control of anterior pituitary function in humans.
    Melis GB; Mais V; Paoletti AM; Antinori D; de Ruggiero A; Fioretti P
    Adv Biochem Psychopharmacol; 1986; 42():219-42. PubMed ID: 3020897
    [No Abstract]   [Full Text] [Related]  

  • 6. Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans.
    Vescovi PP; Volpi R; Coiro V
    Alcohol; 1998 Nov; 16(4):325-8. PubMed ID: 9818985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaba-ergic and dopaminergic regulation of thyroid stimulating hormone. Effects of baclofen and metoclopramide.
    Elias AN; Szekeres AV; Stone S; Weathersbee P; Valenta LJ; Haw T
    Horm Res; 1984; 19(3):171-5. PubMed ID: 6425188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GH after baclofen and diazepam].
    Carletti P; Morosini PP; Ferretti GF; Campanella N
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2351-4. PubMed ID: 6279128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined treatment with dopaminergic and GABA-ergic drugs on the threshold for maximal electroconvulsions in mice.
    Czuczwar SJ
    Pol J Pharmacol Pharm; 1981; 33(1):25-35. PubMed ID: 6265890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalproex sodium attenuates growth hormone response to baclofen in healthy human males.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    Neuropsychopharmacology; 1998 May; 18(5):370-6. PubMed ID: 9536450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the GABA-ergic link in the development of the tranquilizing effect in cats].
    Kozlovskaia MM; Kharlamov AN; Raevskiĭ KS; Val'dman AV
    Biull Eksp Biol Med; 1981; 91(1):45-8. PubMed ID: 6111364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteers.
    Koulu M; Lammintausta R
    Acta Neurol Scand Suppl; 1983; 95():91-4. PubMed ID: 6428151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
    Kleinrok Z; Czuczwar SJ; Kozicka M
    Epilepsia; 1980 Oct; 21(5):519-29. PubMed ID: 6252007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
    Sethy VH
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease.
    Volpi R; Scaglioni A; Marcato A; Caffarra P; Rossi G; Caffarri G; Delsignore R; Chiodera P; Coiro V
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):259-64. PubMed ID: 1772578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content.
    Mailman RB; Mueller RA; Breese GR
    Life Sci; 1978 Aug; 23(6):623-7. PubMed ID: 211362
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine mediated behavior and GABA influence.
    Westerling P; Lindgren S; Höglund U
    Pharmacol Biochem Behav; 1988 Nov; 31(3):593-6. PubMed ID: 3251243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the benzodiazepine derivative, diazepam, on the clonidine-stimulated human growth hormone secretion.
    Koulu M; Pihlajamäki K; Huupponen R
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1316-8. PubMed ID: 6841564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroendocrine effects of a sodium valproate and diazepam combination in the male rat].
    Hariton C; Valli M; Courtière A; Mesdjian E; Baret A; Jadot G
    J Pharmacol; 1984; 15(2):137-42. PubMed ID: 6429450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.
    György L
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):280-6. PubMed ID: 526081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.